The DOI matches its Crossref record; 248 of the 248 references it cites were found in a registry or an index.
Amyotrophic lateral sclerosis
Open accessAbstract
Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, is characterized by the degeneration of both upper and lower motor neurons, which leads to muscle weakness and eventual paralysis. Until recently, ALS was classified primarily within the neuromuscular domain, although new imaging and neuropathological data have indicated the involvement of the non-motor neuraxis in disease pathology. In most patients, the mechanisms underlying the development of ALS are poorly understood, although a subset of patients have familial disease and harbour mutations in genes that have various roles in neuronal function. Two possible disease-modifying therapies that can slow disease progression are available for ALS, but patient management is largely mediated by symptomatic therapies, such as the use of muscle relaxants for spasticity and speech therapy for dysarthria. Amyotrophic lateral sclerosis (ALS) is characterized by the degeneration of both upper and lower motor neurons, which leads to progressive muscle weakness and paralysis. This Primer by Hardiman and colleagues provides a detailed overview of the epidemiology, pathophysiology and diagnosis of ALS, and discusses the management of both the motor and non-motor symptoms of this condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–248 of 248
Iyer, P. M., Egan, C., Pinto‐Grau, M., Burke, T., Elamin, M., Nasseroleslami, B., Pender, N. P., Lalor, E. C., & Hardiman, O. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128682 · Cited by 76
Self-citationTrends and determinants of end-of-life practices in ALS in the Netherlands
Maessen, M., Veldink, J. H., Onwuteaka-Philipsen, B. D., de Vries, J. M., Wokke, J. H. J., van der Wal, G., & van den Berg, L. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b87983 · Cited by 74
Bede, P., Iyer, P. M., Schuster, C., Elamin, M., McLaughlin, R. L., Kenna, K. P., & Hardiman, O. M. (2016) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2016.1173702 · Cited by 74
Self-citationvan den Berg‐Vos, R. M., Visser, J., Kalmijn, S., Fischer, K., de Visser, M., de Jong, J. M. B. V., de Haan, R. J., Franssen, H., Wokke, J. H. J., & van den Berg, L. H. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.91 · Cited by 73
RandomForest4Life: A Random Forest for predicting ALS disease progression
Hothorn, T., & Jung, H. H. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.893361 · Cited by 73
Presymptomatic ALS genetic counseling and testing
Benatar, M. G., Stanislaw, C. L., Reyes, E., Hussain, S., Cooley, A., Fernandez, M. C., Dauphin, D. D., Michon, S.-C., Andersen, P. M., & Wuu, J. (2016) · Neurology · doi:10.1212/wnl.0000000000002773 · Cited by 73
The ALS Patient Care Database: Insights into End-of-Life Care in ALS
Mandler, R. N., Anderson, F., Miller, R., Clawson, L., Cudkowicz, M., & Bene, M. L. D. (2001) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820152882214 · Cited by 72
Corrado, L., Carlomagno, Y., Falasco, L., Mellone, S., Godi, M., Cova, E., Cereda, C., Testa, L., Mazzini, L., & D’Alfonso, S. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.02.011 · Cited by 71
A case-control study of hormonal exposures as etiologic factors for ALS in women
Rooney, J. P. K., Visser, A. E., D’Ovidio, F., Vermeulen, R. C. H., Beghi, E., Chiò, A., Veldink, J. H., Logroscino, G., van den Berg, L. H., & Hardiman, O. M. (2017) · Neurology · doi:10.1212/wnl.0000000000004390 · Cited by 69
Self-citationMarino, M., Papa, S., Crippa, V., Nardo, G., Peviani, M., Cheroni, C., Trolese, M. C., Lauranzano, E., Bonetto, V., Poletti, A., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.06.026 · Cited by 68
Self-citationVajda, A., McLaughlin, R. L., Heverin, M., Thorpe, O., Abrahams, S., Al‐Chalabi, A., & Hardiman, O. M. (2017) · Neurology · doi:10.1212/wnl.0000000000003686 · Cited by 68
Self-citationPinto, S., & de Carvalho, M. A. (2016) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2016.1249486 · Cited by 66
Benefits, pitfalls, and future design of population-based registers in neurodegenerative disease
Rooney, J. P. K., Brayne, C., Tobin, K., Logroscino, G., Glymour, M. M., & Hardiman, O. M. (2017) · Neurology · doi:10.1212/wnl.0000000000004038 · Cited by 66
Self-citationRafiq, M. K., Bradburn, M. J., Proctor, A., Billings, C., Bianchi, S. M., McDermott, C. J., & Shaw, P. J. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1051992 · Cited by 65
Self-citationOtomo, A., Pan, L., & Hadano, S. (2012) · Neurology Research International · doi:10.1155/2012/498428 · Cited by 65
Amlie‐Wolf, A., Ryvkin, P., Tong, R., Dragomir, I. C., Suh, E. R., Xu, Y., Deerlin, V. M. V., Gregory, B. D., Kwong, L. K., Trojanowski, J. Q., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141836 · Cited by 64
Hadano, S., Mitsui, S., Pan, L., Otomo, A., Kubo, M., Sato, K., Ono, S., Onodera, W., Abe, K., Chen, X.-P., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw180 · Cited by 62
Laslo, P., Lipski, J., Nicholson, L. F. B., Miles, G. B., & Funk, G. D. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7653 · Cited by 60
Performance predictors of brain–computer interfaces in patients with amyotrophic lateral sclerosis
Geronimo, A. M., Simmons, Z., & Schiff, S. J. (2016) · Journal of Neural Engineering · doi:10.1088/1741-2560/13/2/026002 · Cited by 60
Self-citationHeat-shock protein dysregulation is associated with functional and pathological TDP-43 aggregation
Chang, H., Hou, S., Way, T., Wong, C., & Wang, I. (2013) · Nature Communications · doi:10.1038/ncomms3757 · Cited by 57
Walsh, M. J., Cooper‐Knock, J., Dodd, J. E., Stopford, M. J., Mihaylov, S. R., Kirby, J., Shaw, P. J., & Hautbergue, G. M. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12187 · Cited by 56
Self-citationBergemalm, D., Forsberg, K., Srivastava, V., Graffmo, K. S., Andersen, P. M., Brännström, T., Wingsle, G., & Marklund, S. L. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06753.x · Cited by 54
Religiousness is related to quality of life in patients with ALS
Walsh, S., Bremer, B. A., Felgoise, S. H., & Simmons, Z. (2003) · Neurology · doi:10.1212/01.wnl.0000058767.05265.f3 · Cited by 54
Self-citationPsychological morbidity in ALS: The importance of psychological assessment beyond depression alone
Felgoise, S. H., Chakraborty, B. H., Bond, E., Rodriguez, J. L., Bremer, B. A., Walsh, S., Lai, E. C., McCluskey, L. F., & Simmons, Z. (2010) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482961003667630 · Cited by 51
Self-citationGcn5- and Elp3-induced histone H3 acetylation regulates hsp70 gene transcription in yeast
Han, Q., Lü, J., Duan, J., Su, D., Hou, X., Li, F., Wang, X., & Huang, B. (2008) · Biochemical Journal · doi:10.1042/bj20070578 · Cited by 50
Structure and function of mRNA export adaptors
Walsh, M. J., Hautbergue, G. M., & Wilson, S. A. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380232 · Cited by 50
FUS-regulated RNA metabolism and DNA damage repair
Zhou, Y., Liu, S., Öztürk, A., & Hicks, G. G. (2014) · Rare Diseases · doi:10.4161/rdis.29515 · Cited by 50
Receiving the news of a diagnosis of motor neuron disease: What does it take to make it better?
Aoun, S. M., Breen, L. J., Howting, D. A., Edis, R. H., Oliver, D., Henderson, R. D., O’Connor, M., Harris, R., & Birks, C. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1111907 · Cited by 48
Amyotrophic lateral sclerosis: Time for research on psychological intervention?
Pagnini, F., Simmons, Z., Corbo, M., & Molinari, E. (2012) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2011.653572 · Cited by 45
Self-citationIncidence of amyotrophic lateral sclerosis in the Faroe Islands
Joensen, P. (2011) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2011.01611.x · Cited by 43
Riluzole 5 mg/mL oral suspension: for optimized drug delivery in amyotrophic lateral sclerosis
Dyer, A. M., & Smith, A. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s123776 · Cited by 43
Prognostic Role of Serum Levels of Uric Acid in Amyotrophic Lateral Sclerosis
Oh, S., Baek, S., Park, J., Piao, L., Oh, K., & Kim, S. H. (2015) · Journal of Clinical Neurology · doi:10.3988/jcn.2015.11.4.376 · Cited by 42
Death with dignity in Washington patients with amyotrophic lateral sclerosis
Wang, L. H., Elliott, M. A., Henson, L. J., Gerena-Maldonado, E., Strom, S., Downing, S., Vetrovs, J., Kayihan, P., Paul, P., Kennedy, K. J., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003335 · Cited by 40
Incidence of Amyotrophic Lateral Sclerosis Among American Indians and Alaska Natives
Gordon, P. H., Mehal, J. M., Holman, R. C., Rowland, L. P., Rowland, A. S., & Cheek, J. E. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.929 · Cited by 39
Botulinum toxin-A injections vs radiotherapy for drooling in ALS
Weikamp, J. G., Schinagl, D. A. X., Verstappen, C. C. P., Schelhaas, H. J., Swart, B. J. M. D., & Kalf, J. G. (2016) · Acta Neurologica Scandinavica · doi:10.1111/ane.12559 · Cited by 38
Moglia, C., Calvo, A., Canosa, A., Bertuzzo, D., Cugnasco, P., Solero, L., Grassano, M., Bersano, E., Cammarosano, S., Manera, U., et al. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2017.1336560 · Cited by 37
Increased incidence of deep venous thrombosis in ALS
Qureshi, M., Cudkowicz, M., Zhang, H., & Raynor, E. M. (2007) · Neurology · doi:10.1212/01.wnl.0000250444.30622.ee · Cited by 36
Barclay, R., & Tate, R. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.12.003 · Cited by 36
Green, C., Kiebert, G. M., Murphy, C., Mitchell, J. D., O'Brien, M. R., Burrell, A. D., & Leigh, P. N. (2003) · Quality of Life Research · doi:10.1023/a:1025052609818 · Cited by 35
Rare genetic variation in UNC13A may modify survival in amyotrophic lateral sclerosis
Gaastra, B., Shatunov, A., Pulit, S. L., Jones, A. R., Sproviero, W., Gillett, A. C., Chen, Z., Kirby, J., Fogh, I., Powell, J. F., et al. (2016) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2016.1213852 · Cited by 29
Self-citationAmyotrophic lateral sclerosis: a comparison of two staging systems in a population‐based study
Ferraro, D., Consonni, D., Fini, N., Fasano, A., Giovane, C. D., Emilia Romagna Registry for ALS (ERRALS) Group, & Mandrioli, J. (2016) · European Journal of Neurology · doi:10.1111/ene.13053 · Cited by 27
National Study of Muscle Cramps in ALS in the USA
Stephens, H., Joyce, N. C., & Oskarsson, B. (2016) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2016.1245755 · Cited by 27
Coping strategies in relation to quality of life in amyotrophic lateral sclerosis
Montel, S., Albertini, L., & Spitz, É. (2011) · Muscle & Nerve · doi:10.1002/mus.22270 · Cited by 25
Abdelnour-Mallet, M., Verschueren, A., Guy, N., Soriani, M., Chalbi, M., Gordon, P., Salachas, F., Bruneteau, G., Forestier, N. L., Lenglet, T., et al. (2010) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2010.531741 · Cited by 24
Heiman-Patterson, T. D., Blankenhorn, E. P., Sher, R. B., Jiang, J., Welsh, P., Dixon, M. C., Jeffrey, J., Wong, P. C., Cox, G. A., & Alexander, G. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117848 · Cited by 20
Reniers, W., Schrooten, M., Claeys, K. G., Tilkin, P., D’Hondt, A., van Reijen, D., Couwelier, G., Lamaire, N., Robberecht, W., Fieuws, S., et al. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2017.1288254 · Cited by 20
Self-citationCell to Cell Spreading of Misfolded Proteins as a Therapeutic Target in Motor Neuron Disease
Pasquali, L., Lenzi, P., Biagioni, F., Siciliano, G., & Fornai, F. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140601161534 · Cited by 16
Hereditary motor neuropathies and motor neuron diseases: which is which
Hanemann, C. O., & Ludolph, A. C. (2002) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608202760839003 · Cited by 14
Research works printed but not linked: 6
- Wong, Y. C. & Holzbaur, E. L. Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation. Proc. Natl Acad. Sci. USA 111, E4439–E4448 (2014).
- Pizzo, E. et al. Ribonuclease/angiogenin inhibitor 1 regulates stress-induced subcellular localization of angiogenin to control growth and survival. J. Cell Sci. 126, 4308–4319 (2013).
- Garcia, M. L. et al. Mutations in neurofilament genes are not a significant primary cause of non-SOD1-mediated amyotrophic lateral sclerosis. Neurobiol. Dis. 21, 102–109 (2006). · doi:10.1016/j.nbd.2005.06.016
- Mastaglia, F. L. & Needham, M. Inclusion body myositis: a review of clinical and genetic aspects, diagnostic criteria and therapeutic approaches. J. Clin. Neurosci. 22, 6–13 (2015). · doi:10.1016/j.jocn.2014.09.012
- Juntas-Morales, R., Pageot, N., Alphandery, S. & Camu, W. The use of peripherally inserted central catheter in amyotrophic lateral sclerosis patients at a later stage. Eur. Neurol. 77, 87–90 (2017). · doi:10.1159/000454858
- Gladman, M., Dehaan, M., Pinto, H., Geerts, W. & Zinman, L. Venous thromboembolism in amyotrophic lateral sclerosis: a prospective study. Neurology 82, 1674–1677 (2014). · doi:10.1212/wnl.0000000000000405
Cited by
Ageing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310
The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
Cabral-Pacheco, G. A., Garza-Veloz, I., Castruita-De la Rosa, C., Ramirez-Acuña, J. M., Perez-Romero, B. A., Guerrero-Rodriguez, J. F., Martinez-Avila, N., & Martinez-Fierro, M. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249739 · Cited by 1,820
An Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases
Teleanu, D. M., Niculescu, A.-G., Lungu, I. I., Radu, C. I., Vladâcenco, O., Roza, E., Costăchescu, B., Grumezescu, A. M., & Teleanu, R. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115938 · Cited by 1,085
Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases
Kapellos, T. S., Bonaguro, L., Gemünd, I., Reusch, N., Saglam, A., Hinkley, E. R., & Schultze, J. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02035 · Cited by 890
Epidemiology of amyotrophic lateral sclerosis: an update of recent literature
Longinetti, E., & Fang, F. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000730 · Cited by 620
Metadata
- Authors
- Hardiman, O., Al-Chalabi, A., Chio, A., Corr, E. M., Logroscino, G., Robberecht, W., Shaw, P. J., Simmons, Z., & van den Berg, L. H.
- Venue
- Nature Reviews Disease Primers
- Published
- 2017-10-05
- Volume
- 3
- Issue
- 1
- Pages
- 17071-17071
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W4211041983
- Cited by
- 1,414
- References
- 248
- FWCI
- 8.92
- Type
- journal article
- Language
- en
- Update notices
- correction (2017-10-20)
- Open access
- hybrid
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.